laitimes

Zhengzhou Jinyu medical related personnel involved in violation of the law on the prevention and control of infectious diseases, the stock plunged nearly 6%

"We just started to do nucleic acid testing to use the Golden Mile Mini Program, the first round of nucleic acid testing can find the results, but the second round of only some of the results, and then each round can not find the nucleic acid test results, the latest notification we received is not to use this small program for nucleic acid testing."

A citizen of Yuzhou City wanted to reveal to a health times reporter. Another citizen also said, "Our first four rounds of nucleic acid testing used the golden domain, but there has been no result, so the residents in the back have not used it, and they directly scanned the ID card for nucleic acid testing." ”

On January 12, a health times reporter called the Yuzhou Municipal Public Security Bureau, and its staff said, "We cannot disclose the details of the case." And said that at present, the case-handling unit is in the Xuchang Municipal Public Security Bureau, and subsequently, the reporter called the Xuchang Municipal Public Security Bureau case-handling department, and the telephone has not been connected. The reporter noted that in response to this problem, Jinyu Medical also issued an official statement saying, "On January 2, Zhengzhou Jinyu received a notice from the Health and Construction Department of Yuzhou City, a subsidiary of Xuchang City, Henan Province, requesting to participate in the epidemic prevention and control screening in Yuzhou City, Zhengzhou Jinyu immediately put into work, on January 10, the local staff of our company was investigated and inquired by the public security organs, and it is still in the investigation stage and has not been concluded." ”

Zhengzhou Jinyu medical related personnel involved in violation of the law on the prevention and control of infectious diseases, the stock plunged nearly 6%

Articles 65-77 of Chapter 8 of the Law of the People's Republic of China on the Prevention and Control of Infectious Diseases provide a detailed description of the concealment, misreporting, or delaying of the reporting of the epidemic situation of infectious diseases.

Previously, in Beijing, Hebei, Tianjin and other epidemics, there have been cases in which testing institutions are suspected of violating the provisions of the Law on the Prevention and Control of Infectious Diseases, falsifying test results, or violating operational procedures. For example, on January 17, 2021, the Xingtai City Epidemic Press Conference reported that Jinan Huaxi Medical Laboratory Co., Ltd. undertook the second round of nucleic acid testing tasks in Longyao County, and Zhai Mou, the person in charge of the company's collection point, falsely reported to the county health bureau that all the samples were negative when the samples had not been tested and the results were unknown.

According to the Health Times reporter, Zhengzhou Jinyu Clinical Laboratory Center Co., Ltd. is the fifth subsidiary of Jinyu Medical Group, located in the Zhengzhou Pilot Free Trade Zone in Henan Province, founded on January 28, 2008, is the first third-party inspection institution approved by the Henan Provincial Health Department with a medical institution practice license, and has 37 service outlets in Henan Province, covering all counties and districts in 18 prefectures and cities in Henan Province. According to enterprise investigation data, Zhengzhou Jinyu Clinical Laboratory Center Co., Ltd. is directly owned by Guangzhou Jinyu Medical Laboratory Group Co., Ltd. 100%.

The reporter noted that

Jinyu Medical opened with a sharp decline, down 5.79% as of press time at 91 yuan / share.

Zhengzhou Jinyu medical related personnel involved in violation of the law on the prevention and control of infectious diseases, the stock plunged nearly 6%

Read on